Dendritic cell vaccines in melanoma: From promise to proof?

This publication has 173 references indexed in Scilit:

• Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
  Cancer Immunology, Immunotherapy, 2008
• Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
  Nature Reviews Immunology, 2007
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
  Nature Medicine, 2007
• Depletion of CD4⁺CD25⁺ human regulatory T cells in vivo: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
  International Journal of Cancer, 2007
• Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity
  British Journal of Cancer, 2006
• Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination
  Nuclear Medicine and Biology, 2006
• Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
  Cancer Gene Therapy, 2005
• Toll-like receptor control of the adaptive immune responses
  Nature Immunology, 2004
• Toll-like receptor signalling
  Nature Reviews Immunology, 2004
• mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation
  Leukemia, 2002